运营

同位素输送园区

马萨诸塞州北比勒里卡

SPECT manufacturing and distribution

Where diagnostic imaging gets its supply

Hospitals and imaging centers across North America depend on technetium-99m to see inside the human body. It has a half-life of six hours, so it can’t be stockpiled. Hospitals keep a Tc-99m generator on site instead, which produces a fresh supply each day. We make those generators here, one of only two major sites in the United States producing them.

We also make the imaging agents used in heart and brain scans and the gas used for lung studies. Manufacturing, quality control, packaging and distribution all run from this one campus, and have since 1969.

主要设施数据

PRODUCTS

SPECT diagnostic radiopharmaceuticals

状态

运行中

区别

Producing Tc‑99m generators since 1969

Regulatory Status

FDA-registered drug establishment

Distribution

North America and select international markets

“Reliable medicine depends on a reliable supply chain. We’re building it from isotope production through to delivery.”

Mike Rossi, SHINE MEDICAL CEO

THE CAMPUS

Where a week's supply starts

An aerial look at the campus that manufactures and ships SPECT products across North America.

图片库

Inside SPECT manufacturing and delivery

Four buildings, 218,000 square feet, and the people who keep diagnostic imaging supplied.

Aerial view of the Isotope Delivery Campus surrounded by trees

Isotope Delivery Campus buildings behind a mowed lawn

WHAT HAPPENS HERE

Capabilities built over five decades

Integrated quality operations

Quality control, calibration, and radiological safety are built into daily operations, so every batch is tested and released before it ships.

SPECT manufacturing at scale

Tc-99m generators, CardioLite and NeuroLite imaging agents used in heart and brain scans, and Xenon Xe-133 gas for lung studies.

An established path to patients

Since 1969, this campus has supplied the generators behind nuclear imaging, from its early adoption to its place in routine care today.

One of two in the country

One of two major U.S. manufacturing sites for these products. Once complete, Chrysalis will make it the only one supplied by domestically produced isotopes.

From production to the patient

The molybdenum-99 (Mo-99) inside Tc-99m generators comes from overseas reactors, most of them nearing the end of their working lives. Because Mo-99 decays quickly, roughly a fifth of any shipment is lost each day it’s in transit. Outages at those reactors have caused recurring shortages, forcing hospitals to reschedule patient tests.

We’re bringing that supply chain home. Our plan is that Chrysalis will produce Mo-99 in Janesville, Wisconsin and ship it to this campus, where it will be loaded into generators and delivered.

Reliable medicine needs a reliable supply chain.

新闻中心